Protein and production process and use thereof
Granted 23 Jul 2013 · 2 office actions
Current assignee: TEIJIN PHARMA LIMITED · originally Teijin Limited
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Kei Yamana, Eiji Ochiai, Yoshimasa Takahashi, Yoshiaki Azuma +2 · Examiner: Christine J Saoud · AU 1646 · TC 1600
Life of the patent
13 dated eventsAbstract
[PROBLEMS] To provide a polypeptide having a novel structure and showing an activity of inhibiting angiogenesis or an activity of inhibiting osteoclastogenesis, and to provide a recombinant protein by constructing a method of purifying the above protein. To provide an ingredient useful in designing remedies for tendinitis, rheumatoid arthritis, arthritis deformans, malignant tumor, etc. [MEANS FOR SOLVING PROBLEMS] A novel soluble polypeptide protein.
Claims
9 · 3 independent · depth 6Classifications
12 codes- C12N5/00
- C12P21/06
- C07H21/04
- C12P21/04
- C12N15/00
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
1 priority documents›Priority documents — 1
| Type | Document | Date |
|---|---|---|
| related publication | US 20090313711 A1 | 17 Dec 2009 |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock